Laurus Labs

BSE : 540222 | NSE : LAURUSLABS
Industry : Pharma Formulations | ISIN : INE947Q01028 | FreeFloat : 65.08% | FnO : Yes | LotSize : 1100
Intellectual Capital (IC)8,476.76
Net Worth (NW)3,975.45
Intrinsic Worth (IW)12,452.21
Market Cap (MC)20,212.88
Economic Value Added22.69
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)68.07%
IC Gross Margin (EBITDA/IC)21.27%
IC Net Margin (NPT/IC)11.24%
Knowledge Turnover (Sales/IC)0.75
Market to Intrinsic Value (MC/IW)1.62
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 231.17Rs. 375.25
27 Mar 2023 ---- Rs. 297.80
-1.55     -0.52%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 303.30SellAvoid
KB > 50% : Yes50 DMA : Rs. 325.74
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
839.14
840.82
193.45
147.40
126.74
110.15
98.15
Jun-20
C
974.32
981.41
285.41
236.61
221.47
171.78
172.51
Sep-20
C
1138.84
1143.96
378.99
327.99
314.31
242.27
250.54
Dec-20
C
1288.42
1295.35
433.23
381.59
364.16
272.85
274.18
Mar-21
C
1411.93
1416.45
476.71
423.08
401.17
296.92
296.82
Jun-21
C
1278.50
1284.35
401.20
342.66
316.05
241.61
241.07
Sep-21
C
1203.48
1206.31
347.91
284.72
262.59
203.95
203.29
Dec-21
C
1028.76
1034.09
290.62
226.60
203.50
154.95
154.35
Mar-22
C
1424.83
1426.12
397.82
332.08
301.53
231.72
233.64
Jun-22
C
1538.94
1540.69
455.61
384.82
355.57
252.23
251.38
Sep-22
C
1575.89
1577.00
449.61
367.77
327.66
233.39
228.94
Dec-22
C
1544.82
1546.25
404.48
320.04
277.33
202.54
202.57
* C - Consolidated, S - Standalone